Researchers based in Germany developed a highly specific and sensitive approach to measuring antibodies against the new SARS-CoV-2 coronavirus for population-scale immune surveillance. The antibody positivity was defined as a dual-positive response against both the receptor-binding domain and nucleocapsid proteins of SARS-CoV-2.
In this study of 15,771 children aged 1 to 18 years living in Bavaria, Germany published on October 28, 2020, the antibody prevalence from April 2020 was 6-fold higher than 'authority-reported' cases. And showed marked variation between the (7) Bavarian regions and was not associated with age or sex.
The transmission in children with virus-positive family members was 35%, with 47% of positive children found to be asymptomatic. A positive highlight from this study was the antibody frequency in newborns was just 0.47%.